Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
This editorial provides an update on research & innovation (R&I) needs that can support EFSA's regulatory science in the coming years. The paper presents research needs for EFSA's work in a number of domains: omics technologies; gut microbiome; new approach methodologies (NAMs); allergenicity risk assessment; aggregate exposure assessment and environmental risk assessment (ERA). In briefly describing R&I needs, the document also addresses emerging challenges and opportunities. The authors acknowledge that this overview is not exhaustive and refer to earlier publications for additional R&I needs, as well as to the roadmaps for a more in-depth presentation. Finally, the document calls for transdisciplinary research, reflecting on the interdependencies between human, animal, plant and environmental health. This editorial will be valuable to stakeholders, research agenda setters and funders, both public and private, in formulating calls for research and project funding related to food safety.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12001418 | PMC |
| http://dx.doi.org/10.2903/j.efsa.2025.e220401 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Integrated PBPK modelling for PFOA exposure and risk assessment.
Environ Res
October 2025
Aristotle University of Thessaloniki, Department of Chemical Engineering, Environmental Engineering Laboratory, University Campus, Thessaloniki, 54124, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km,
Per- and polyfluoroalkyl substances (PFASs) pose significant public health concerns due to their environmental persistence, bioaccumulation, and ubiquitous presence in human biomonitoring (HBM) data, despite regulatory restrictions. This study establishes a deterministic pharmacokinetic model for perfluorooctanoic acid (PFOA), enabling the estimation of PFOA concentrations in major human organs, even at low doses. The model integrates accumulation and recirculation mechanisms of PFOA in hepatic and renal tissues, leveraging publicly available HBM datasets (e.
View Article and Find Full Text PDFThis editorial provides an update on research & innovation (R&I) needs that can support EFSA's regulatory science in the coming years. The paper presents research needs for EFSA's work in a number of domains: omics technologies; gut microbiome; new approach methodologies (NAMs); allergenicity risk assessment; aggregate exposure assessment and environmental risk assessment (ERA). In briefly describing R&I needs, the document also addresses emerging challenges and opportunities.
View Article and Find Full Text PDFThis Scientific Report was carried out in the context of the self-task mandate (M-2023-00097) of the EFSA's Scientific Committee on 'Guidance on the use of biomarkers of effect in regulatory risk assessment of chemicals'. In the first phase, the project on biomarkers of effect started with a feasibility study (EFSA-Q-2024-00128), with the intention to look closer at definitions and descriptions of biomarkers of effect, as well as to explore several concepts related to the context of application and other scientific principles to be further considered for its development. In addition, relevant activities, initiatives and knowledge in this area were collected and analysed within a complementary mapping study.
View Article and Find Full Text PDFHealth benefits and risks of fermented foods-the PIMENTO initiative.
Front Nutr
September 2024
Research Division Microbial Food Systems, Agroscope, Berne, Switzerland.
Article Synopsis
- * Seven of the reviews will look into clinical and biological effects of FF on various health indicators across organ systems, while the other nine will explore broader topics like bioactive compounds, safety, and personalized nutrition related to FF.
- * Each review will consist of a systematic analysis of human studies, insights into the mechanisms behind observed health outcomes, and characterization of the FF being studied, culminating in a strategic roadmap for future research in the field.
Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data - The European Joint Programme HBM4EU.
Environ Int
August 2024
Department of Environmental and Occupational Health, Santé publique France, The French Public Health Agency (SpFrance, ANSP), 12 rue du Val d'Osne, Saint-Maurice Cedex 94415, France.
Background: Bisphenol A (BPA; or 4,4'-isopropylidenediphenol) is an endocrine disrupting chemical. It was widely used in a variety of plastic-based manufactured products for several years. The European Food Safety Authority (EFSA) recently reduced the Tolerable Daily Intake (TDI) for BPA by 20,000 times due to concerns about immune-toxicity.
View Article and Find Full Text PDF